Another innovative approach involves CXCL12-encapsulated PLGA/pluronic NPs designed to disrupt the CXCL12/CXCR4 signaling axis—a key driver of tumor cell migration and metastasis. This evidence concerns the gene CXCL12 and neoplasm.